Chubb Valuation

Is 0VQD undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0VQD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 0VQD ($292.01) is trading below our estimate of fair value ($593.41)

Significantly Below Fair Value: 0VQD is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0VQD?

Key metric: As 0VQD is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 0VQD. This is calculated by dividing 0VQD's market cap by their current earnings.
What is 0VQD's PE Ratio?
PE Ratio11.7x
EarningsUS$10.00b
Market CapUS$117.04b

Price to Earnings Ratio vs Peers

How does 0VQD's PE Ratio compare to its peers?

The above table shows the PE ratio for 0VQD vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average9x
ADM Admiral Group
18.5x12.1%UK£7.4b
BEZ Beazley
4.7x-17.9%UK£4.8b
HSX Hiscox
6.2x-2.4%UK£3.5b
DLG Direct Line Insurance Group
6.8x9.1%UK£2.1b
0VQD Chubb
11.7x1.0%US$117.0b

Price-To-Earnings vs Peers: 0VQD is expensive based on its Price-To-Earnings Ratio (11.7x) compared to the peer average (9x).


Price to Earnings Ratio vs Industry

How does 0VQD's PE Ratio compare vs other companies in the European Insurance Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
0VQD 11.7xIndustry Avg. 11.8xNo. of Companies13PE0816243240+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 0VQD is good value based on its Price-To-Earnings Ratio (11.7x) compared to the European Insurance industry average (11.8x).


Price to Earnings Ratio vs Fair Ratio

What is 0VQD's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0VQD PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio11.7x
Fair PE Ratio12.4x

Price-To-Earnings vs Fair Ratio: 0VQD is good value based on its Price-To-Earnings Ratio (11.7x) compared to the estimated Fair Price-To-Earnings Ratio (12.4x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0VQD forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$292.01
US$298.91
+2.4%
8.2%US$349.00US$245.00n/a21
Nov ’25US$279.66
US$297.71
+6.5%
8.3%US$349.00US$245.00n/a21
Oct ’25US$292.14
US$282.96
-3.1%
8.5%US$349.00US$236.00n/a22
Sep ’25US$282.27
US$277.86
-1.6%
6.4%US$305.00US$236.00n/a21
Aug ’25US$271.14
US$276.43
+2.0%
6.7%US$305.00US$236.00n/a21
Jul ’25US$255.42
US$270.73
+6.0%
5.5%US$305.00US$236.00n/a22
Jun ’25US$268.41
US$269.50
+0.4%
5.0%US$294.00US$236.00n/a22
May ’25US$250.57
US$266.65
+6.4%
6.3%US$297.00US$226.00n/a23
Apr ’25US$259.49
US$261.17
+0.6%
7.2%US$285.00US$226.00n/a23
Mar ’25US$250.53
US$259.13
+3.4%
7.3%US$285.00US$226.00n/a23
Feb ’25US$245.12
US$253.74
+3.5%
7.6%US$285.00US$220.00n/a23
Jan ’25US$225.73
US$243.68
+8.0%
7.4%US$275.00US$203.00n/a22
Dec ’24US$228.67
US$244.68
+7.0%
7.7%US$277.00US$203.00n/a22
Nov ’24US$221.30
US$244.19
+10.3%
7.6%US$277.00US$203.00US$279.6621
Oct ’24US$208.14
US$238.55
+14.6%
8.6%US$270.00US$192.00US$292.1420
Sep ’24US$203.38
US$238.55
+17.3%
8.6%US$270.00US$192.00US$282.2720
Aug ’24US$203.86
US$238.30
+16.9%
8.5%US$270.00US$192.00US$271.1420
Jul ’24US$191.49
US$237.13
+23.8%
8.9%US$270.00US$192.00US$255.4220
Jun ’24US$186.45
US$239.50
+28.5%
7.9%US$270.00US$193.00US$268.4119
May ’24US$201.74
US$241.40
+19.7%
7.7%US$270.00US$193.00US$250.5720
Apr ’24US$194.85
US$242.80
+24.6%
8.4%US$270.00US$185.00US$259.4920
Mar ’24US$211.37
US$243.70
+15.3%
7.3%US$270.00US$205.00US$250.5320
Feb ’24US$214.34
US$245.05
+14.3%
7.2%US$270.00US$205.00US$245.1220
Jan ’24US$222.79
US$235.89
+5.9%
9.4%US$270.00US$175.00US$225.7318
Dec ’23US$217.67
US$232.68
+6.9%
8.9%US$270.00US$175.00US$228.6719
Nov ’23US$215.17
US$231.30
+7.5%
9.2%US$270.00US$175.00US$221.3020

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies